NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
Condition(s):Menkes Disease; Occipital Horn SyndromeLast Updated:January 10, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Menkes Disease; Occipital Horn SyndromeLast Updated:January 10, 2023Recruiting
Condition(s):Parkinson’s DiseaseLast Updated:June 25, 2018Completed
Condition(s):Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear PalsyLast Updated:March 2, 2022Withdrawn
Condition(s):Hypotension, Orthostatic; Hypotension; Spinal Cord InjuriesLast Updated:June 26, 2023Completed
Condition(s):Spinal Cord Injury; HypotensionLast Updated:July 30, 2013Completed
Condition(s):Gait Disorders, NeurologicLast Updated:March 29, 2013Withdrawn
Condition(s):Multiple System AtrophyLast Updated:August 25, 2020Completed
Condition(s):Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency; Non-Diabetic Neuropathy; Neurogenic Orthostatic HypotensionLast Updated:February 9, 2024Completed
Condition(s):Parkinson’s Disease; Freezing of Gait; Cognitive Ability, GeneralLast Updated:November 3, 2016Unknown status
Condition(s):Autonomic Failure; Pure Autonomic Failure; Multiple System Atrophy; Parkinson Disease; Orthostatic HypotensionLast Updated:March 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.